Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single Agent
- Status
- TERMINATED
- Phase
- PHASE2
Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate Treatment Customized According to RAP80 and BRCA1 in Patients With Advanced Lung Carcinoma
- Status
- TERMINATED
- Phase
- PHASE3
Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Perioperative Therapy for Resectable Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)
- Status
- COMPLETED
- Phase
- PHASE1
Assessment of the Efficacy of a Neoadjuvant Combination: "Chemotherapy-targeted Therapy" in Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE)
- Status
- TERMINATED
- Phase
- PHASE2
Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostate
- Status
- WITHDRAWN
- Phase
- PHASE2
Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Proper Dosage of Lovastatin and Docetaxel for Patients With Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE2